Anti-VSV-G [8G5F11] Antibody

Anti-VSV-G [8G5F11] Antibody

This monoclonal antibody reacts with VSV-G protein from the Indiana serotype.

Highlights:

-Shows reactivity against VSV-G pseudotyped lentiviruses (see references below)

-Suitable for Western Blot, Flow Cytometry and Immunofluorescence applications

Vesicular stomatitis virus (VSV) is a well studied, enveloped, negative-strand RNA virus. The VSV genome encodes for 5 proteins: N, P, M, G, and L. The G protein (glycoprotein) is located at the virion surface and is responsible for virus attachment and penetration. Additionally, many lentivrial vectors are pseudotyped with VSV-G from the Indiana serotype.

货号 品名 规格 库存 价格
EB0010
Anti-VSV-G [8G5F11] Antibody
100ug 现询
Regular Price:6900元
On Sale:
产品详情

Product Type:Antibody
Name:Anti-VSV-G [8G5F11]
Antigen:VSV-G
Accession ID:P03522
Host:Mouse
Isotype:IgG2a kappa
Clonality:Monoclonal
Clone Name:8G5F11
Specificity:VSV-Ind glycoprotein (G) protein
Reactivity:Human
Immunogen:VSV infection
Format:Liquid
Purification Method:Protein G purified
Buffer:PBS, 0.05% (w/v) Sodium Azide
Tested Applications:Western blot (1:1000), flow cytometry, immunofluorescence
Concentration:1mg/mL
Amount:100uL
Storage:-20C (avoid repeated freeze / thaw cycles)
Shipped:Cold packs

文档资料

产品说明书：auto_1317Anti-VSV-G [8G5F11] Antibody


产品源头

From the laboratory of Douglas S. Lyles, PhD, Wake Forest School of Medicine.

参考文献

  1. Gregory DA, Olinger GY, Lucas TM, Johnson MC. Diverse viral glycoproteins as well as CD4 co-package into the same human immunodeficiency virus (HIV-1) particles. Retrovirology. 2014 Apr 3;11(1):28.

  2. Kubo S, Mitani K. A New Hybrid System Capable of Efficient Lentiviral Vector Production and Stable Gene Transfer Mediated by a Single Helper-Dependent Adenoviral Vector. JVirol 77: 2964-2971, 2003.

  3. Kobayashi M, Iida A, Ueda Y, and Hasegawa M. Pseudotyped Lentivirus Vectors Derived from Simian Immunodeficiency Virus SIVagm with Envelope Glycoproteins from Paramyxovirus. JVirol 77: 2607-2614, 2003.

  4. Burns JC, Friedmann T, Driever W, Burrascano M, Yee JK. Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: Concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells. PNAS 90: 8033-8037, 1993.

  5. Vandepol SB, Lefrancois L, Holland JJ. Sequences of the Major Anitbody Binding Epitopes of the Indiana Serotype of Vesicular Stomatitis Virus. Virology 148: 312-325 (1986).

  6. Lefrancios L, Lyles DS. The interaction of antibody with the major surface glycoprotein of vesicular stomatitis virus. I. Analysis of neutralizing epitopes with monoclonal antibodies. Virology 121: 157-167, 1982.

  7. Boso G, Somia NV. Characterization of resistance to rhabdovirus and retrovirus infection in a human myeloid cell line. PLoS One. 2015 Mar 26;10(3):e0121455. doi: 10.1371/journal.pone.0121455. View Article

  8. Zhang J, Reiling C, Reinecke JB, Prislan I, Marky LA, Sorgen PL, Naslavsky N, Caplan S. Rabankyrin-5 interacts with EHD1 and Vps26 to regulate endocytictrafficking and retromer function. Traffic. 2012 May;13(5):745-57. View Article

  9. McNulty S, Flint M, Nichol ST, Spiropoulou CF. Host mTORC1 signaling regulatesandes virus replication. J Virol. 2013 Jan;87(2):912-22. View Article

  10. Guzzo C, Fox J, Lin Y, Miao H, Cimbro R, Volkman BF, Fauci AS, Lusso P. The CD8-derived chemokine XCL1/lymphotactin is a conformation-dependent,broad-spectrum inhibitor of HIV-1. PLoS Pathog. 2013;9(12):e1003852. View Article

  11. Chen D, Gibson ES, Kennedy MJ. A light-triggered protein secretion system. J Cell Biol. 2013 May 13;201(4):631-40. View Article

  12. Xing M, Peterman MC, Davis RL, Oegema K, Shiau AK, Field SJ. GOLPH3 drives cell migration by promoting Golgi reorientation and directional trafficking to the leading edge. Mol Biol Cell. 2016 Dec 1;27(24):3828-3840. PubMed PMID: 27708138; PubMed Central PMCID: PMC5170606.View Article

  13. Yonemura Y, Li X, Müller K, Krämer A, Atigbire P, Mentrup T, Feuerhake T, Kroll T, Shomron O, Nohl R, Arndt HD, Hoischen C, Hemmerich P, Hirschberg K, Kaether C. Inhibition of cargo export at ER exit sites and the trans-Golgi network by the secretion inhibitor FLI-06. J Cell Sci. 2016 Oct 15;129(20):3868-3877. PubMed PMID: 27587840. View Article

  14. Yuan WC, Lee YR, Lin SY, Chang LY, Tan YP, Hung CC, Kuo JC, Liu CH, Lin MY, Xu M, Chen ZJ, Chen RH. K33-Linked Polyubiquitination of Coronin 7 by Cul3-KLHL20 Ubiquitin E3 Ligase Regulates Protein Trafficking. Mol Cell. 2014 May 22;54(4):586-600. doi: 10.1016/j.molcel.2014.03.035. PubMed PMID: 24768539. View Article

  15. McNulty S, Flint M, Nichol ST, Spiropoulou CF. Host mTORC1 signaling regulates andes virus replication. J Virol. 2013 Jan;87(2):912-22. doi: 10.1128/JVI.02415-12. PubMed PMID: 23135723; PubMed Central PMCID: PMC3554081. View Article

  16. Ferlin A, Raux H, Baquero E, Lepault J, Gaudin Y. Characterization of pH-sensitive molecular switches that trigger the structural transition of vesicular stomatitis virus glycoprotein from the postfusion state toward the prefusion state. J Virol. 2014 Nov;88(22):13396-409. doi: 10.1128/JVI.01962-14. PubMed PMID: 25210175; PubMed Central PMCID: PMC4249061. View Article

  17. Rao M, Song W, Jiang A, Shyr Y, Lev S, Greenstein D, Brantley-Sieders D, Chen J. VAMP-associated protein B (VAPB) promotes breast tumor growth by modulation of Akt activity. PLoS One. 2012;7(10):e46281. doi: 10.1371/journal.pone.0046281. PubMed PMID: 23049696; PubMed Central PMCID: PMC3462209. (supplemental information) View Article

  18. Swick A, Baltes A, Yin J. Visualizing infection spread: dual-color fluorescent reporting of virus-host interactions. Biotechnol Bioeng. 2014 Jun;111(6):1200-9. doi: 10.1002/bit.25170. PubMed PMID: 24338628; PubMed Central PMCID: PMC4004699. View Article

  19. Rogalin HB, Heldwein EE. Characterization of Vesicular Stomatitis Virus Pseudotypes Bearing Essential Entry Glycoproteins gB, gD, gH, and gL of Herpes Simplex Virus 1. J Virol. 2016 Oct 28;90(22) View Article

  20. Baquero E, Albertini AA, Raux H, Abou-Hamdan A, Boeri-Erba E, Ouldali M, Buonocore L, Rose JK, Lepault J, Bressanelli S, Gaudin Y. Structural intermediates in the fusion-associated transition of vesiculovirus glycoprotein. EMBO J. 2017 Mar 1;36(5):679-692. doi: 10.15252/embj.201694565. PubMed PMID: 28188244; PubMed Central PMCID: PMC5331758. View Article

  21. Bowen AB, Bourke AM, Hiester BG, Hanus C, Kennedy MJ. Golgi-independent secretory trafficking through recycling endosomes in neuronal dendrites and spines. Elife. 2017 Sep 6;6. pii: e27362.View Article

  22. Sakata M, Tani H, Anraku M, Kataoka M, Nagata N, Seki F, Tahara M, Otsuki N, Okamoto K, Takeda M, Mori Y. Analysis of VSV pseudotype virus infection mediated by rubella virus envelope proteins. Sci Rep. 2017 Sep 14;7(1):11607. View Article

  23. Anandi L, Chakravarty V, Ashiq KA, Bodakuntla S, Lahiri M. DNA-PK plays a central role in transformation of breast epithelial cells following alkylation damage. J Cell Sci. 2017 Sep 18. pii: jcs.203034. View Article

  24. Milani M, Annoni A, Bartolaccini S, Biffi M, Russo F, Di Tomaso T, Raimondi A, Lengler J, Holmes MC, Scheiflinger F, Lombardo A, Cantore A, Naldini L. Genome editing for scalable production of alloantigen-free lentiviral vectors for in vivo gene therapy. EMBO Mol Med. 2017 Nov;9(11):1558-1573. View Article

  25. Tezuka K, Okuma K, Kuramitsu M, Matsuoka S, Tanaka R, Tanaka Y, Hamaguchi I. Control of HTLV-1 Infection by Eliminating Envelope Protein-Positive Cells with Recombinant Vesicular Stomatitis Viruses Encoding HTLV-1 Primary Receptor. J Virol. 2017 Dec 6. pii: JVI.01885-17. View Article

  26. Nikolic J, Belot L, Raux H, Legrand P, Gaudin Y, A Albertini A. Structural basis for the recognition of LDL-receptor family members by VSV glycoprotein. Nat Commun. 2018 Mar 12;9(1):1029. View Article

  27. Felt SA, Droby GN, Grdzelishvili VZ. Ruxolitinib and Polycation Combination Treatment Overcomes Multiple Mechanisms of Resistance of Pancreatic Cancer Cells to Oncolytic Vesicular Stomatitis Virus. J Virol. 2017 Jul 27;91(16). pii: e00461-17. View Article

  28. Ci Y, Yang Y, Xu C, Shi L. Vesicular stomatitis virus G protein transmembrane region is crucial for the hemi-fusion to full fusion transition. Sci Rep. 2018 Jul 13;8(1):10669. View Article

  29. Tijani M, Munis AM, Perry C, Sanber K, Ferraresso M, Mukhopadhyay T, Themis M, Nisoli I, Mattiuzzo G, Collins MK, Takeuchi Y. Lentivector Producer Cell Lines with Stably Expressed Vesiculovirus Envelopes. Mol Ther Methods Clin Dev. 2018 Aug 7;10:303-312. View Article

  30. Johnson B, VanBlargan LA, Xu W, White JP, Shan C, Shi PY, Zhang R, Adhikari J, Gross ML, Leung DW, Diamond MS, Amarasinghe GK. Human IFIT3 Modulates IFIT1 RNA Binding Specificity and Protein Stability. Immunity. 2018 Mar 20;48(3):487-499.e5. View Article

  31. Rahajeng J, Kuna RS, Makowski SL, Tran TTT, Buschman MD, Li S, Cheng N, Ng MM, Field SJ. Efficient Golgi Forward Trafficking Requires GOLPH3-Driven, PI4P-Dependent Membrane Curvature. Dev Cell. 2019 Jun 7. pii: S1534-5807(19)30451-4. View Article

  32. Munis AM, Tijani M, Hassall M, Mattiuzzo G, Collins MK, Takeuchi Y. Characterization of Antibody Interactions with the G Protein of Vesicular Stomatitis Virus Indiana Strain and Other Vesiculovirus G Proteins. J Virol. 2018 Nov 12;92(23). pii: e00900-18. View Article

  33. Moskovskich A, Goldmann U, Kartnig F, Lindinger S, Konecka J, Fiume G, Girardi E, Superti-Furga G. The transporters SLC35A1 and SLC30A1 play opposite roles in cell survival upon VSV virus infection. Sci Rep. 2019 Jul 18;9(1):10471. View Article

  34. Gale TV, Horton TM, Hoffmann AR, Branco LM, Garry RF. Host Proteins Identified in Extracellular Viral Particles as Targets for Broad-Spectrum Antiviral Inhibitors. J Proteome Res. 2019 Jan 4;18(1):7-17. View Article

  35. Moskovskich A, Goldmann U, Kartnig F, et al. The transporters SLC35A1 and SLC30A1 play opposite roles in cell survival upon VSV virus infection. Sci Rep. 2019;9(1):10471. Published 2019 Jul 18. View article

  36. Rossor AM, Sleigh JN, Groves M, et al. Loss of BICD2 in muscle drives motor neuron loss in a developmental form of spinal muscular atrophy. Acta Neuropathol Commun. 2020;8(1):34. Published 2020 Mar 17. View article

  37. Lucken-Ardjomande Häsler S, Vallis Y, Pasche M, McMahon HT. GRAF2, WDR44, and MICAL1 mediate Rab8/10/11-dependent export of E-cadherin, MMP14, and CFTR ΔF508. J Cell Biol. 2020;219(5):e201811014. View article

  38. Van Bergen NJ, Ahmed SM, Collins F, et al. Mutations in the exocyst component EXOC2 cause severe defects in human brain development. J Exp Med. 2020;217(10):e20192040. View article

  39. Johnson MC, Lyddon TD, Suarez R, Salcedo B, LePique M, Graham M, Ricana C, Robinson C, Ritter DG. Optimized pseudotyping conditions for the SARS COV-2 Spike glycoprotein. J Virol. 2020 Aug 11:JVI.01062-20. View article

  40. Azad T, Singaravelu R, Crupi MJF, Jamieson T, Dave J, Brown EEF, Rezaei R, Taha Z, Boulton S, Martin NT, Surendran A, Poutou J, Ghahremani M, Nouri K, Whelan JT, Duong J, Tucker S, Diallo JS, Bell JC, Ilkow CS. Implications for SARS-CoV-2 Vaccine Design: Fusion of Spike Glycoprotein Transmembrane Domain to Receptor-Binding Domain Induces Trimerization. Membranes (Basel). 2020 Aug 30;10(9):E215. View article

  41. Rossor AM, Sleigh JN, Groves M, Muntoni F, Reilly MM, Hoogenraad CC, Schiavo G. Loss of BICD2 in muscle drives motor neuron loss in a developmental form of spinal muscular atrophy. Acta Neuropathol Commun. 2020 Mar 17;8(1):34. View article

  42. Lester S, Harcourt J, Whitt M, Al-Abdely HM, Midgley CM, Alkhamis AM, Aziz Jokhdar HA, Assiri AM, Tamin A, Thornburg N. Middle East respiratory coronavirus (MERS-CoV) spike (S) protein vesicular stomatitis virus pseudoparticle neutralization assays offer a reliable alternative to the conventional neutralization assay in human seroepidemiological studies. Access Microbiol. 2019 Sep 11;1(9):e000057. View article

  43. Yamaguchi H, Honda S, Torii S, Shimizu K, Katoh K, Miyake K, Miyake N, Fujikake N, Sakurai HT, Arakawa S, Shimizu S. Wipi3 is essential for alternative autophagy and its loss causes neurodegeneration. Nat Commun. 2020 Oct 20;11(1):5311. View article 

  44. Chen DY, Khan N, Close BJ, Goel RK, Blum B, Tavares AH, Kenney D, Conway HL, Ewoldt JK, Kapell S, Chitalia VC, Crossland NA, Chen CS, Kotton DN, Baker SC, Connor JH, Douam F, Emili A, Saeed M. SARS-CoV-2 desensitizes host cells to interferon through inhibition of the JAK-STAT pathway. bioRxiv [Preprint]. 2020 Oct 28:2020.10.27.358259. View article 

  45. Wei J, Alfajaro MM, DeWeirdt PC, Hanna RE, Lu-Culligan WJ, Cai WL, Strine MS, Zhang SM, Graziano VR, Schmitz CO, Chen JS, Mankowski MC, Filler RB, Ravindra NG, Gasque V, de Miguel FJ, Patil A, Chen H, Oguntuyo KY, Abriola L, Surovtseva YV, Orchard RC, Lee B, Lindenbach BD, Politi K, van Dijk D, Kadoch C, Simon MD, Yan Q, Doench JG, Wilen CB. Genome-wide CRISPR Screens Reveal Host Factors Critical for SARS-CoV-2 Infection. Cell. 2020 Oct 20:S0092-8674(20)31392-1.  View article 

  46. Vogel AB, et al. BNT162b vaccines protect rhesus macaques from SARS-CoV-2. Nature. 2021 Apr;592(7853):283-289. View article